PROM1 and colorectal carcinoma: These data suggested an enrichment of CD133+ cellular subpopulation in CRC patients while the CD133+ cellular subpopulation could be used as the baseline measurement for CTCs in the peripheral blood of CRC patients in FACS analysis.